Skip to main content
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: Clin Sci (Lond). 2021 Apr 30;135(8):1053–1063. doi: 10.1042/CS20201498

Figure 4. Sex specific effects of THS on immune cell populations.

Figure 4.

For immune cell populations identified in Figure 3 as divergent between control and THS exposed mice, males and females, as well as immune subsets, were compared as described in the legend to Figure 3.

A. Bone marrow (BM) B-cells (B220+/CD19+), mature B-cells (B220+/CD19+/IgK+) and immature B-cells (B220+/CD19+/IgK−).

B. Bone marrow myeloid cells (CD19−/CD11b+), monocytes (CD19−/CD11b+/Gr-1neg-lo) and neutrophils (CD19−/CD11b+/Gr-1mod-hi).

C. Spleen (Sp) B-cells (B220+/CD19+), mature B-cells (B220+/CD19+/IgK+) and immature B-cells (B220+/CD19+/IgK−).

D. Spleen T-cells (CD3+), T-helper cells (CD3+/CD4+) and T-suppressor cells (CD3+/CD8+).

E. Peripheral blood (PB) T-cells (CD3+), T-helper cells (CD3+/CD4+) and T-suppressor cells (CD3+/CD8+).

F. Peripheral blood myeloid cells (CD19−/CD11b+), monocytes (CD19−/CD11b+/Gr-1neg-lo) and neutrophils (CD19−/CD11b+/Gr-1mod-hi).